Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Durbin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|August 10, 2002
A variance-stabilizing transformation for gene-expression microarray dataB P Durbin, J S Hardin, D M Hawkins, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 31, 2014
Pharmacokinetic and pharmacodynamic analysis comparing diverse effects of detomidine, medetomidine, and dexmedetomidine in the horse: a population analysisK N Grimsrud, S Ait-Oudhia, B P Durbin-Johnson, et al.
Oncogene|July 27, 2017
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancerL S D'Abronzo, S Bose, M E Crapuchettes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|August 10, 2002
A variance-stabilizing transformation for gene-expression microarray dataB P Durbin, J S Hardin, D M Hawkins, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 31, 2014
Pharmacokinetic and pharmacodynamic analysis comparing diverse effects of detomidine, medetomidine, and dexmedetomidine in the horse: a population analysisK N Grimsrud, S Ait-Oudhia, B P Durbin-Johnson, et al.
Oncogene|July 27, 2017
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancerL S D'Abronzo, S Bose, M E Crapuchettes, et al.
Pageof 1